Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 235 participants.

Also called NCT06121518

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 235 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06121518
Other papers using this trial's data
  • Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial Clinical therapeutics, 2026-03 DOI, PubMed 41672793

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06121518. Randomized; double masking; primary purpose treatment. Start 2023-07-31 (actual); primary completion 2024-03-22 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy
Condition
Essential Hypertension
Intervention (Drug)
D064 and D702, QD
Intervention (Drug)
D064 and Placebo of D702, QD
Intervention (Drug)
Placebo of D064 and D702, QD
Lead sponsor
Chong Kun Dang Pharmaceutical (class: industry)

Record details

Record id
cardio:ct-nct06121518
Content hash
95b2bc7fcb3a145d1a22c11839f1794ee0b3987e969c4b420dff8dfe432b7422